SECUADO: payments to doctors
Payments that named SECUADO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $454K
- Providers
- 4,885
- Transactions
- 12,146
- Average per transaction
- $37
The per-transaction average — $37 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,885 providers the average total is $93, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Noven Pharmaceuticals, Inc. | $251,784 | 55.5% |
| Noven Therapeutics, LLC | $201,793 | 44.5% |